When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
TCON - Tracon Pharma advances pivot envafolimab study with FDA
TRACON Pharmaceuticals Inc.
Tracon Pharmaceuticals (NASDAQ:TCON) has filed the ENVASARC study protocol with the FDA as part of its IND application. The application cross references the open envafolimab IND maintained by company's corporate partners 3D Medicines and Alphamab Oncology.
More news on: TRACON Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,